Quarterly report pursuant to Section 13 or 15(d)

Equity

v3.24.3
Equity
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Equity Equity
 
As of September 30, 2024, we had remaining capacity under our at-the-market stock offering program equal to an aggregate gross sales price of $300 million in common shares.

We declared dividends per common share of $0.295 in the three months ended September 30, 2024, $0.285 in the three months ended September 30, 2023, $0.885 in the nine months ended September 30, 2024 and $0.855 in the nine months ended September 30, 2023.

During the nine months ended September 30, 2024, a CDPLP limited partner converted 40,000 common units in CDPLP for an equal number of common shares.

See Note 15 for disclosure of common share activity pertaining to our share-based compensation plans.